CardiologyPhase IIEnrolling

HEART-RHYTHM Study

Atrial Fibrillation

Study Overview

An investigational study evaluating a novel antiarrhythmic agent for patients with paroxysmal atrial fibrillation. The study uses continuous cardiac monitoring to assess rhythm control efficacy.

Inclusion Criteria

  • Adults aged 40-75 years
  • Documented paroxysmal AF
  • At least 2 AF episodes in past 3 months
  • Currently on rate control medication

Exclusion Criteria

  • Permanent AF
  • Prior ablation procedure
  • Heart failure with reduced EF
  • QTc prolongation

Study Details

Phase
Phase II
Duration
24 weeks
Location
Main Facility
Compensation
Up to $550 for time and travel
Check Eligibility

Have questions? Contact us